Biotek-snakken — Oktober 2023
-
Prövarinitierade SESAR-studien uppnår planerad patientrekrytering
Prövarinitierade SESAR-studien uppnår planerad patientrekrytering
Sedana Medical AB (publ) meddelar att rekryteringen av de planerade 700 patienterna i SESAR-studien
News Powered by Cision (news.cision.com)
(MÅN, OKT 23, 2023 08:00 CET - Sedana Medical AB)
-
(THE SESAR INVESTIGATOR-INITIATED TRIAL COMPLETES PATIENT ENROLLMENT)
-
Sedana Medical AB’s Interim report January-September 2023
All-time-high Q3 sales and further steps towards ex-US profitability
-
Calliditas Asien-partner får Nefecon-godkännande i Macao
Läkemedelsbolaget Calliditas asiatiska partner Everest Medicines meddelar att Nefecon fått grönt ljus i Macao för behandling av njursjukdomen IgAN.
-
Biotech Stocks Facing FDA Decision In November 2023 https://www.proinvestor.com/investornyt/1070743/biotech-stocks-facing-fda-decision-in-november-2023
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind